218. Attenuated PreFusion F Antibody Response to RSV Vaccines in Solid Organ Transplant RecipientsAndrew H. Karaba, William A. Werbel, Camille Hage et al.|Open Forum Infectious Diseases|2025Cited by 1
Long-Term Safety of Respiratory Syncytial Virus Vaccination in Solid Organ Transplant RecipientsX. Green, William A. Werbel, Chadi A. Hage et al.|American Journal of Transplantation|2025Cited by 0
Equivalent RSV Specific IgG and IgA Increases After Vaccination in Transplant RecipientsKatrin Gaardbo Kuhn, J Ronald Bailey, Jie Xue et al.|American Journal of Transplantation|2025Cited by 0
Variant Updated Novavax COVID-19 Vaccination is a Safe Alternative to mRNA Vaccines in Transplant RecipientsChadi A. Hage, Andrew H. Karaba, I. Sengsouk et al.|American Journal of Transplantation|2025Cited by 0
SARS-CoV-2 Infection Incidence in Solid Organ Transplant Recipients during XBB and JN.1 Sublineage WavesW. Gallo, William A. Werbel, Jian Xue et al.|American Journal of Transplantation|2025Cited by 0